Theralase Technologies Inc (TLTFF)

[was CUIN2]

Theralase to Present at Global Investment Conference

Accesswire September 12, 2016
TORONTO, ON / ACCESSWIRE / September 12, 2016 / Theralase Technologies Inc. ("Theralase®" or the "Company") (TSX-V: TLT) (OTC: TLTFF), a leading biotech company focused on the commercialization of medical devices to eliminate pain and the development of Photo Dynamic Compounds ("PDCs") to destroy cancer, announced today that the President and CEO of the Company, Roger Dumoulin-White, will present at 10:25 am on September 12, 2016 at the Rodman and Renshaw 18th Annual Global Investment Conference in New York City.